• נגישות
    • Volociximab Chimeric Recombinant Human Monoclonal Antibody (M200 (Volociximab))

    Volociximab Chimeric Recombinant Human Monoclonal Antibody (M200 (Volociximab))

    MA551585
    The antibody binds to human alpha 5 Beta 1 integrin with a Kd of 0.367 nM (determined by Biacore), an EC50 of 0.2 nM and an IC50 of 2.3 nM. Volociximab is a biosimilar that targets ITGA5.
    Read more ...
    Certifications

    CAT NUM
    PRODUCT NAME
    Pack Size
    PRICE
    QUANTITY
     
    CAT NUM: MA551585
    Volociximab Chimeric Recombinant Human Monoclonal Antibody (M200 (Volociximab))
    Pack Size: 200 μg
    PRICE: 

    Antigen
    Volociximab Chimeric
    Applications
    Inhibition Assays
    Classification
    Recombinant Monoclonal
    Clone
    M200 (Volociximab)
    Concentration
    1 mg/mL
    Conjugate
    Unconjugated
    Form
    Liquid
    Formulation
    PBS with 0.02% ProClin 300
    Gene Alias
    558480-40-3; M20
    Host Species
    Human
    Immunogen
    Heterodimeric Human alpha 5 Beta 1 Fc fusion protein.
    Isotype
    IgG4 κ
    Primary or Secondary
    Primary
    Product Type
    Antibody
    Purification Method
    Protein A
    Regulatory Status
    RUO
    Content And Storage
    Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
    Target Species
    Human
    Brand
    Invitrogen
    Pack Size
    200 μg
    Storage Temp
    Freezer (-5 to -30 C)
    Category
    Primary Antibodies

    The antibody binds to human alpha 5 Beta 1 integrin with a Kd of 0.367 nM (determined by Biacore), an EC50 of 0.2 nM and an IC50 of 2.3 nM. Volociximab is a biosimilar that targets ITGA5.
    CONTACT US

    Rhenium Ltd
    Tel: +972-8-955-8888
    E-mail:  [email protected] 
     Hasatat 20, P.O.B 180, Modi’in 7171101, Israel
      Customer service via whatsapp